Beranda › Kanker Kolorektal › Utah › West Valley City
Uji klinis Kanker Kolorektal di West Valley City, UT
17 studi untuk Kanker Kolorektal mencari peserta di lokasi sekitar West Valley City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
Menerima pesertaFase 2
- START Mountain Region, West Valley City
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1
- START Mountain Region, West Valley City
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Menerima pesertaFase 1
- ALX Center 4, West Valley City
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
Menerima pesertaFase 1
- START Mountain Region, West Valley City
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Menerima pesertaFase 1
- START Mountain Region, West Valley City
A Study of MGC026 in Participants With Advanced Solid Tumors
Menerima pesertaFase 1
- START Mountain Region, West Valley City
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Menerima pesertaFase 1
- South Texas Accelerated Research Therapeutics Mountain Region, West Valley City
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1
- START Mountain Region, West Valley City
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Menerima pesertaFase 1
- START Mountain Region, LLC., West Valley City
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
Menerima pesertaFase 1
- START Mountain Region, West Valley City
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Menerima pesertaFase 1
- START Mountain Region, LLC, West Valley City
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
Menerima pesertaFase 1
- START Mountain Region, LLC, West Valley City
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Menerima pesertaFase 1/2
- START Mountain Region, West Valley City
A Study of MGC028 in Participants With Advanced Solid Tumors
Menerima pesertaFase 1
- South Texas Accelerated Research Therapeutics (START) Mountain Region, West Valley City
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Menerima pesertaFase 1/2
- START Mountain Region, West Valley City
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1/2
- START Mountain Region, West Valley City
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Menerima pesertaFase 1/2
- START, Mountain Region, West Valley City
Uji klinis Kanker Kolorektal di kota lain
- Houston, TX102 studi
- New York City, NY78 studi
- Nashville, TN69 studi
- Boston, MA63 studi
- Los Angeles, CA59 studi
- Arlington, VA52 studi
- St. Louis, MO50 studi
- San Antonio, TX46 studi
- Philadelphia, PA44 studi
- Grand Rapids, MI40 studi
- Baldwin Park, CA37 studi
- Chicago, IL34 studi
Studi lain di West Valley City
- Kanker Paru Non-Sel Kecil25 studi
- Kanker Payudara13 studi
- Kanker Payudara Triple-Negatif13 studi
- Kanker Metastatik13 studi
- Kanker Pankreas12 studi
- Kanker (semua jenis)11 studi
- Kanker Ovarium11 studi
- Karsinoma Sel Skuamosa Kepala dan Leher11 studi
- Kanker Endometrium10 studi
- Kanker Lambung8 studi
- Karsinoma Sel Skuamosa Esofagus7 studi
- Kanker Paru Sel Kecil7 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.